Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
31 Jul 2024 |
On P&L |
The Company releases the press release related to the first half 2024 financial results
|
Download |
|
31 Jul 2024 |
On P&L |
The Company releases the first half 2024 financial results presentation
|
Download |
|
26 Jun 2024 |
On corporate transactions |
ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives
|
Download |
|
24 Jun 2024 |
On business and financial situation |
ROVI publishes the press release in relation to information and guidance on its strategic plan for expansion and growth
|
Download |
|
08 May 2024 |
On P&L |
The Company releases the press release related to the first three months of 2024 financial results
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
17 Dec 2021 |
On business and financial situation |
ROVI reports that the CHMP has issued a positive opinion on Okedi® for the treatment for schizophrenia
|
Download |
|
13 Dec 2021 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 6 December 2021 and 10 December 2021
|
Download |
|
06 Dec 2021 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 29 November 2021 and 3 December 2021
|
Download |
|
22 Nov 2021 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 15 November 2021 and 19 November 2021
|
Download |
|
16 Nov 2021 |
Liquidity and counterparty agreements |
The Company informs of the termination of the Liquidity Agreement
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
08 Jan 2018 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted in the fourth quarter of 2017
|
Download |
|
21 Dec 2017 |
Préstamos, créditos y avales |
ROVI and the EIB agree to sign a loan to boost research into drug administration and prolonged-release technologies
|
Download |
|
08 Nov 2017 |
Información sobre Resultados |
ROVI releases the press release related to the nine-month period ended 30 September 2017 results
|
Download |
|
08 Nov 2017 |
Información sobre Resultados |
ROVI releases the presentation related to the nine-month period ended 30 September 2017 results.
|
Download |
|
24 Oct 2017 |
Otros sobre negocio y situación financiera |
The Company releases the presentation related to the update of its Phase III-Prima 3 Risperidone ISM® project.
|
Download |
Pages
